Licia Uccelli
Via L. Borsari, 46
Ferrara, 44121, Italy
Ferrara, 44121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
In Vitro Radiobiological Evaluation of [64Cu]CuCl2 for Theranostic Applications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 29, 2026
Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals.
Journal: Molecules (Basel, Switzerland)
Published: November 28, 2025
Colorectal Cancer: A Landscape of New Potential Radiopharmaceuticals.
Journal: Molecular diagnosis & therapy
Published: November 05, 2025
Illuminating Multiple Sclerosis: Next-Generation PET Tracers for Molecular Insights.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 04, 2025
Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms.
Journal: EJNMMI research
Published: May 23, 2025
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer.
Journal: Molecular diagnosis & therapy
Published: April 29, 2025
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives.
Journal: Cancers
Published: April 08, 2025
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma.
Journal: Biomolecules
Published: October 31, 2024
Molecular Imaging in Cancer Chemoresistance: What's Brewing?
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 14, 2024
Is There a Role for FAPI PET in Urological Cancers?
Journal: Molecular diagnosis & therapy
Published: July 26, 2024
Recent Advances in Preclinical Studies of the Theranostic Agent [64Cu]CuCl2.
Journal: Molecules (Basel, Switzerland)
Published: June 30, 2024
Last Updated: 09/26/2026